PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 26.00
-0.50 (-1.89%)
Sep 5, 2025, 5:30 PM CET
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 874.27 million as of September 5, 2025. Its market cap has decreased by -18.44% in one year.
Market Cap
874.27M
Enterprise Value
906.61M
Revenue
344.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.00
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 874.27M, a decrease of -66.25%. That is a compound annual growth rate of -22.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 874.27M | -6.67% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 237.12B |
| Novartis AG | 201.17B |
| Lonza Group AG | 40.61B |
| Galderma Group AG | 33.64B |
| Alcon | 31.37B |
| Sandoz Group AG | 21.16B |
| Straumann Holding AG | 15.08B |
| Sonova Holding AG | 14.16B |